Penn’s Angela DeMichele, MD, MSCE, Part of Team Awarded Stand Up 2 Cancer Grant
Perelman School of Medicine at the University of PennsylvaniaA new $3 million grant to support a clinical trial evaluating a combination therapy to prevent triple-negative breast cancer from recurring, which will be led in the clinic by Angela DeMichele, MD, MSCE, the Alan and Jill Miller Professor in Breast Cancer Excellence in the Abramson Cancer Center (ACC) at the University of Pennsylvania and co-director of the ACC’s 2-PREVENT Translational Center of Excellence. The grant was awarded by Stand Up 2 Cancer (SU2C) in partnership with Genentech, and will be administered by the organization’s scientific partner, the American Association for Cancer Research (AACR).